
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW000278 |
drug action
Candesartan Action PathwayHomo sapiens
Candesartan (also named Blopress or Atacand) is an active metabolite of angiotensin II receptor blockers (ARBs) pro drug, candesartan cilexetil. Candesartan cilexetil converts to candesartan rapidly in gastrointestinal tract during absorption. Candesartan competes with angiotensin II to bind type-1 angiotensin II receptor (AT1) in many tissues (e.g. vascular smooth muscle, the adrenal glands, etc.) to prevent increasing sodium, water reabsorption and peripheral resistance (that will lead to increasing blood pressure) via aldosterone secretion that is caused by angiotensin II. Therefore, action of candesartan binding to AT1 will result in decreasing blood pressure. For more information on the effects of aldosterone on electrolyte and water excretion, refer to the description of the spironolactone or triamterene pathways, which describes the mechanism of direct aldosterone antagonists. Candesartan is an effective agent for reducing blood pressure and may be used to treat essential hypertension and heart failure.
|
Creator: WishartLab Created On: August 22, 2013 at 10:45 Last Updated: August 22, 2013 at 10:45 |
PW126185 |
disease
Cancer Pathogenesis (Hallmarks) - DRAFT1Homo sapiens
The hallmarks of cancer, the Warburg review
|
Creator: Nitya Khetarpal Created On: August 06, 2021 at 13:36 Last Updated: August 06, 2021 at 13:36 |
PW123786 |
disease
Cancer IIHomo sapiens
|
Creator: Guest: Anonymous Created On: February 04, 2020 at 07:37 Last Updated: February 04, 2020 at 07:37 |
PW123784 |
disease
Cancer 1580739799Homo sapiens
|
Creator: Guest: Anonymous Created On: February 03, 2020 at 07:24 Last Updated: February 03, 2020 at 07:24 |
PW064782 |
disease
CancerHomo sapiens
|
Creator: Carin Li Created On: June 25, 2018 at 15:20 Last Updated: June 25, 2018 at 15:20 |
PW123785 |
disease
cancerHomo sapiens
|
Creator: Guest: Anonymous Created On: February 03, 2020 at 07:30 Last Updated: February 03, 2020 at 07:30 |
PW064723 |
disease
CancerBacteria
|
Creator: Guest: Anonymous Created On: April 21, 2018 at 19:06 Last Updated: April 21, 2018 at 19:06 |
PW000093 |
disease
Canavan DiseaseHomo sapiens
Canavan Disease (Canavan-Van Bogaert-Bertrand Disease; Aminoacylase 2 Deficiency; Spongy Degeneration of the Central Nervous System; Aspartoacylase Deficiency; ASP Deficiency; ACY2 Deficiency; ASPA) is a rare autosomal recessive disease caused by a defect in the ASPA gene which codes for aspartoacylase. A deficiency in this enzyme results in accumulation of N-Acetyl-L-aspartic acid in plasma, spinal fluid, and urine. Symptoms, which present at birth, include myclonus, irritability, hypotonia, motor retardation, and poor head control. The neurological complications are due to demyelination of neurons and leukodystrophy. Premature death often results, though lithium citrate can be used as a treatment.
|
Creator: WishartLab Created On: August 01, 2013 at 15:52 Last Updated: August 01, 2013 at 15:52 |
PW121937 |
disease
Canavan DiseaseRattus norvegicus
Canavan Disease (Canavan-Van Bogaert-Bertrand Disease; Aminoacylase 2 Deficiency; Spongy Degeneration of the Central Nervous System; Aspartoacylase Deficiency; ASP Deficiency; ACY2 Deficiency; ASPA) is a rare autosomal recessive disease caused by a defect in the ASPA gene which codes for aspartoacylase. A deficiency in this enzyme results in accumulation of N-Acetyl-L-aspartic acid in plasma, spinal fluid, and urine. Symptoms, which present at birth, include myclonus, irritability, hypotonia, motor retardation, and poor head control. The neurological complications are due to demyelination of neurons and leukodystrophy. Premature death often results, though lithium citrate can be used as a treatment.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:51 Last Updated: September 10, 2018 at 15:51 |
PW127346 |
disease
Canavan DiseaseHomo sapiens
Canavan Disease (Canavan-Van Bogaert-Bertrand Disease; Aminoacylase 2 Deficiency; Spongy Degeneration of the Central Nervous System; Aspartoacylase Deficiency; ASP Deficiency; ACY2 Deficiency; ASPA) is a rare autosomal recessive disease caused by a defect in the ASPA gene which codes for aspartoacylase. A deficiency in this enzyme results in accumulation of N-Acetyl-L-aspartic acid in plasma, spinal fluid, and urine. Symptoms, which present at birth, include myclonus, irritability, hypotonia, motor retardation, and poor head control. The neurological complications are due to demyelination of neurons and leukodystrophy. Premature death often results, though lithium citrate can be used as a treatment.
|
Creator: Ray Kruger Created On: December 13, 2022 at 16:24 Last Updated: December 13, 2022 at 16:24 |